D
RenovoRx, Inc. RNXT
$0.9403 $0.04695.25% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -19.63% 15.91% -16.47% -3.43% -122.03%
Total Depreciation and Amortization 0.00% -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 360.95% -146.44% 2,581.82% 108.33% 71.88%
Change in Net Operating Assets 82.12% -384.51% -155.69% -28.37% 288.36%
Cash from Operations 31.91% -39.14% -10.76% 4.48% -4.22%
Capital Expenditure 100.00% 83.33% -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 100.00% 83.33% -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.69% 32,660.61% 120.00% -99.84% 78.04%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -99.69% 32,660.61% 120.00% -99.84% 78.04%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -130.53% 408.34% -10.56% -129.63% 128.64%